Skip to content

Comprehensive Strategy to Decolonize Methicillin-resistant Staphylococcus Aureus (MRSA) in the Outpatient Setting

Comprehensive Strategy to Decolonize Methicillin-resistant Staphylococcus Aureus in the Outpatient Setting: a Randomized Controlled Study

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01232231
Enrollment
15
Registered
2010-11-02
Start date
2010-07-31
Completion date
2012-11-30
Last updated
2013-02-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Methicillin-resistant Staphylococcus Aureus

Keywords

methicillin-resistant Staphylococcus aureus, decolonization, random allocation, outpatient

Brief summary

The purpose of this study is to determine the effectiveness of topical and oral antibiotics in eliminating carriage of methicillin-resistant Staphylococcus aureus (MRSA) among those living in the community. We hypothesize that a greater proportion of those who receive intervention will eliminate MRSA carriage compared to those who do not receive any intervention.

Interventions

DRUGpharmacological decolonization treatment

Chlorhexidine gluconate 4% body scrub and 2% shampoo daily PLUS mupirocin 2%, fusidic acid 2%, or chlorhexidine gluconate 0.2% intranasally bid PLUS trimethoprim-sulfamethoxazole 160/800mg po bid or doxycycline 100mg po bid all for 7 days

BEHAVIORALEducation

No pharmacological decolonization treatment but given education regarding personal hygiene and environmental cleaning

Sponsors

Alberta Health services
CollaboratorOTHER
Joseph Kim
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Prior MRSA infection (i.e index case) * Identified as being colonized with MRSA on initial screen

Exclusion criteria

* Are pregnant or breastfeeding. * Have indwelling catheters. * Received prior decolonization treatment within last 6 months of enrollment. * Have allergy to study medication. * Are colonized with MRSA strain resistant to study medication. * Have active infection requiring systemic antimicrobials. * Are household contacts to index case.

Design outcomes

Primary

MeasureTime frame
Eradication of MRSA carriage90 days after randomization

Secondary

MeasureTime frame
Occurrence of MRSA infectionWithin 6 months of randomization

Countries

Canada

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026